Fecal microbiota transplantation (FMT), a technique for replacing gut bacteria, may help with gastrointestinal symptoms of Parkinson’s disease, particularly constipation, according to a review study. While the technique was found to be generally safe and beneficial for gastrointestinal symptoms in Parkinson’s disease, “at this stage, there is no convincing…

People with Parkinson’s disease who switched to the approved oral therapy Crexont, an extended-release formulation of carbidopa and levodopa, from other levodopa-based treatments gained about three additional hours of daily good on time — when symptoms are well-controlled — while also experiencing less off time, or periods…

One of the first symptoms I noticed before I was diagnosed with early-onset Parkinson’s disease, besides a tremor in my pinky fingers, was difficulty managing a knife and fork. It’s one of those weird experiences that you can’t quite imagine until you experience it. And even when you do,…

Levodopa, a standard treatment for Parkinson’s disease, can cause uncontrolled movements called dyskinesia — and this side effect may be driven by changes in a specific receptor component in certain brain cells, a new study shows. Scientists found that an experimental gene therapy…

Montara Therapeutics received a $1 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop a Parkinson’s disease treatment designed to work primarily in the brain and minimize effects on the rest of the body. The new drug will target the mTOR biological pathway.